The food and beverage industry is increasingly adopting the use of artificial intelligence (AI) in the development and scale ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Recognizing that the sponsor is a Congressional Commission, this and subsequent chapters offer a strategic, long-term vision for shaping an R&D ecosystem tailored to biotechnologies enabled by AI/ML ...

Scholars and scientists know well the grueling late-night and weekend hours it takes to write a grant proposal. And the bigger the grant, the more hours required. That's why, in 2017, Johns Hopkins ...